Eintrag weiter verarbeiten
Cancer treatment and survivorship statistics, 2016
Gespeichert in:
Zeitschriftentitel: | CA: A Cancer Journal for Clinicians |
---|---|
Personen und Körperschaften: | , , , , , , , , |
In: | CA: A Cancer Journal for Clinicians, 66, 2016, 4, S. 271-289 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
author_facet |
Miller, Kimberly D. Siegel, Rebecca L. Lin, Chun Chieh Mariotto, Angela B. Kramer, Joan L. Rowland, Julia H. Stein, Kevin D. Alteri, Rick Jemal, Ahmedin Miller, Kimberly D. Siegel, Rebecca L. Lin, Chun Chieh Mariotto, Angela B. Kramer, Joan L. Rowland, Julia H. Stein, Kevin D. Alteri, Rick Jemal, Ahmedin |
---|---|
author |
Miller, Kimberly D. Siegel, Rebecca L. Lin, Chun Chieh Mariotto, Angela B. Kramer, Joan L. Rowland, Julia H. Stein, Kevin D. Alteri, Rick Jemal, Ahmedin |
spellingShingle |
Miller, Kimberly D. Siegel, Rebecca L. Lin, Chun Chieh Mariotto, Angela B. Kramer, Joan L. Rowland, Julia H. Stein, Kevin D. Alteri, Rick Jemal, Ahmedin CA: A Cancer Journal for Clinicians Cancer treatment and survivorship statistics, 2016 Oncology Hematology |
author_sort |
miller, kimberly d. |
spelling |
Miller, Kimberly D. Siegel, Rebecca L. Lin, Chun Chieh Mariotto, Angela B. Kramer, Joan L. Rowland, Julia H. Stein, Kevin D. Alteri, Rick Jemal, Ahmedin 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21349 <jats:title>Abstract</jats:title><jats:p>The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results cancer registries. In addition, current treatment patterns for the most prevalent cancer types are presented based on information in the National Cancer Data Base and treatment‐related side effects are briefly described. More than 15.5 million Americans with a history of cancer were alive on January 1, 2016, and this number is projected to reach more than 20 million by January 1, 2026. The 3 most prevalent cancers are prostate (3,306,760), colon and rectum (724,690), and melanoma (614,460) among males and breast (3,560,570), uterine corpus (757,190), and colon and rectum (727,350) among females. More than one‐half (56%) of survivors were diagnosed within the past 10 years, and almost one‐half (47%) are aged 70 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers. Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence‐based resources are needed to optimize care. <jats:bold>CA Cancer J Clin 2016;66:271‐289. © 2016 American Cancer Society</jats:bold></jats:p> Cancer treatment and survivorship statistics, 2016 CA: A Cancer Journal for Clinicians |
doi_str_mv |
10.3322/caac.21349 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxMzQ5 |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxMzQ5 |
institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
imprint |
Wiley, 2016 |
imprint_str_mv |
Wiley, 2016 |
issn |
0007-9235 1542-4863 |
issn_str_mv |
0007-9235 1542-4863 |
language |
English |
mega_collection |
Wiley (CrossRef) |
match_str |
miller2016cancertreatmentandsurvivorshipstatistics2016 |
publishDateSort |
2016 |
publisher |
Wiley |
recordtype |
ai |
record_format |
ai |
series |
CA: A Cancer Journal for Clinicians |
source_id |
49 |
title |
Cancer treatment and survivorship statistics, 2016 |
title_unstemmed |
Cancer treatment and survivorship statistics, 2016 |
title_full |
Cancer treatment and survivorship statistics, 2016 |
title_fullStr |
Cancer treatment and survivorship statistics, 2016 |
title_full_unstemmed |
Cancer treatment and survivorship statistics, 2016 |
title_short |
Cancer treatment and survivorship statistics, 2016 |
title_sort |
cancer treatment and survivorship statistics, 2016 |
topic |
Oncology Hematology |
url |
http://dx.doi.org/10.3322/caac.21349 |
publishDate |
2016 |
physical |
271-289 |
description |
<jats:title>Abstract</jats:title><jats:p>The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results cancer registries. In addition, current treatment patterns for the most prevalent cancer types are presented based on information in the National Cancer Data Base and treatment‐related side effects are briefly described. More than 15.5 million Americans with a history of cancer were alive on January 1, 2016, and this number is projected to reach more than 20 million by January 1, 2026. The 3 most prevalent cancers are prostate (3,306,760), colon and rectum (724,690), and melanoma (614,460) among males and breast (3,560,570), uterine corpus (757,190), and colon and rectum (727,350) among females. More than one‐half (56%) of survivors were diagnosed within the past 10 years, and almost one‐half (47%) are aged 70 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers. Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence‐based resources are needed to optimize care. <jats:bold>CA Cancer J Clin 2016;66:271‐289. © 2016 American Cancer Society</jats:bold></jats:p> |
container_issue |
4 |
container_start_page |
271 |
container_title |
CA: A Cancer Journal for Clinicians |
container_volume |
66 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792348778602168322 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T18:16:18.527Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cancer+treatment+and+survivorship+statistics%2C+2016&rft.date=2016-07-01&genre=article&issn=1542-4863&volume=66&issue=4&spage=271&epage=289&pages=271-289&jtitle=CA%3A+A+Cancer+Journal+for+Clinicians&atitle=Cancer+treatment+and+survivorship+statistics%2C+2016&aulast=Jemal&aufirst=Ahmedin&rft_id=info%3Adoi%2F10.3322%2Fcaac.21349&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792348778602168322 |
author | Miller, Kimberly D., Siegel, Rebecca L., Lin, Chun Chieh, Mariotto, Angela B., Kramer, Joan L., Rowland, Julia H., Stein, Kevin D., Alteri, Rick, Jemal, Ahmedin |
author_facet | Miller, Kimberly D., Siegel, Rebecca L., Lin, Chun Chieh, Mariotto, Angela B., Kramer, Joan L., Rowland, Julia H., Stein, Kevin D., Alteri, Rick, Jemal, Ahmedin, Miller, Kimberly D., Siegel, Rebecca L., Lin, Chun Chieh, Mariotto, Angela B., Kramer, Joan L., Rowland, Julia H., Stein, Kevin D., Alteri, Rick, Jemal, Ahmedin |
author_sort | miller, kimberly d. |
container_issue | 4 |
container_start_page | 271 |
container_title | CA: A Cancer Journal for Clinicians |
container_volume | 66 |
description | <jats:title>Abstract</jats:title><jats:p>The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results cancer registries. In addition, current treatment patterns for the most prevalent cancer types are presented based on information in the National Cancer Data Base and treatment‐related side effects are briefly described. More than 15.5 million Americans with a history of cancer were alive on January 1, 2016, and this number is projected to reach more than 20 million by January 1, 2026. The 3 most prevalent cancers are prostate (3,306,760), colon and rectum (724,690), and melanoma (614,460) among males and breast (3,560,570), uterine corpus (757,190), and colon and rectum (727,350) among females. More than one‐half (56%) of survivors were diagnosed within the past 10 years, and almost one‐half (47%) are aged 70 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers. Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence‐based resources are needed to optimize care. <jats:bold>CA Cancer J Clin 2016;66:271‐289. © 2016 American Cancer Society</jats:bold></jats:p> |
doi_str_mv | 10.3322/caac.21349 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyMi9jYWFjLjIxMzQ5 |
imprint | Wiley, 2016 |
imprint_str_mv | Wiley, 2016 |
institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
issn | 0007-9235, 1542-4863 |
issn_str_mv | 0007-9235, 1542-4863 |
language | English |
last_indexed | 2024-03-01T18:16:18.527Z |
match_str | miller2016cancertreatmentandsurvivorshipstatistics2016 |
mega_collection | Wiley (CrossRef) |
physical | 271-289 |
publishDate | 2016 |
publishDateSort | 2016 |
publisher | Wiley |
record_format | ai |
recordtype | ai |
series | CA: A Cancer Journal for Clinicians |
source_id | 49 |
spelling | Miller, Kimberly D. Siegel, Rebecca L. Lin, Chun Chieh Mariotto, Angela B. Kramer, Joan L. Rowland, Julia H. Stein, Kevin D. Alteri, Rick Jemal, Ahmedin 0007-9235 1542-4863 Wiley Oncology Hematology http://dx.doi.org/10.3322/caac.21349 <jats:title>Abstract</jats:title><jats:p>The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results cancer registries. In addition, current treatment patterns for the most prevalent cancer types are presented based on information in the National Cancer Data Base and treatment‐related side effects are briefly described. More than 15.5 million Americans with a history of cancer were alive on January 1, 2016, and this number is projected to reach more than 20 million by January 1, 2026. The 3 most prevalent cancers are prostate (3,306,760), colon and rectum (724,690), and melanoma (614,460) among males and breast (3,560,570), uterine corpus (757,190), and colon and rectum (727,350) among females. More than one‐half (56%) of survivors were diagnosed within the past 10 years, and almost one‐half (47%) are aged 70 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers. Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence‐based resources are needed to optimize care. <jats:bold>CA Cancer J Clin 2016;66:271‐289. © 2016 American Cancer Society</jats:bold></jats:p> Cancer treatment and survivorship statistics, 2016 CA: A Cancer Journal for Clinicians |
spellingShingle | Miller, Kimberly D., Siegel, Rebecca L., Lin, Chun Chieh, Mariotto, Angela B., Kramer, Joan L., Rowland, Julia H., Stein, Kevin D., Alteri, Rick, Jemal, Ahmedin, CA: A Cancer Journal for Clinicians, Cancer treatment and survivorship statistics, 2016, Oncology, Hematology |
title | Cancer treatment and survivorship statistics, 2016 |
title_full | Cancer treatment and survivorship statistics, 2016 |
title_fullStr | Cancer treatment and survivorship statistics, 2016 |
title_full_unstemmed | Cancer treatment and survivorship statistics, 2016 |
title_short | Cancer treatment and survivorship statistics, 2016 |
title_sort | cancer treatment and survivorship statistics, 2016 |
title_unstemmed | Cancer treatment and survivorship statistics, 2016 |
topic | Oncology, Hematology |
url | http://dx.doi.org/10.3322/caac.21349 |